Archive

Discover how healthcare investment drives growth, linking public health to stronger GDP performance in emerging markets.

Barrs Pharmaceuticals has exited business rescue after agreeing to sell a controlling stake to Hetero. The deal signals a reset for a local manufacturer that has faced both operational disruption and regulatory pressure.

The US WHO Withdrawal became final in January 2026, raising risks for flu surveillance, outbreak response, and WHO funding as job cuts loom.

South Africa launches the HIV vaccine trial, BRILLIANT 01, testing a new vaccine cocktail designed to prime broadly neutralising antibodies.

Get insights into the Bonitas Tender Dispute as Bonitas reacts to Medscheme’s challenge over service provider appointments.

Bonitas Medscheme split sees Momentum Health and PHA take over key contracts, as a CMS forensic probe and court action continue.

The African Genome Diversity effort led by Wits adds 1,000+ genomes, improving AI models and precision medicine for African populations.

South Africans are reporting rising levels of depression and anxiety. Yet access to care is tightening. High out-of-pocket costs and an entrenched shortage of mental health professionals are leaving many people underserved. In particular, those with the greatest need are most affected.

Understand the longstanding insolvency of the Road Accident Fund and the factors contributing to its financial distress.

Wits Health Research Funding receives a R7m boost from the Oppenheimer Memorial Trust to support those affected by US funding cuts.

Botswana Medicine Shortages are worsening as procurement delays, weak supply chains, and poor data systems leave clinics without drugs.